Renoprotective Effects of Dapagliflozin Versus Pentoxiphylline in Chronic Kidney Disease Patients

NCT06421870 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

210

Enrollment

OTHER

Sponsor class

Conditions

Chronic Kidney Diseases

Interventions

DRUG: Dapagliflozin 10mg Tab
DRUG: Pentoxifylline 400 MG

Sponsor

Ain Shams University